


€132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital?
Europe’s biotech ecosystem just notched a headline-grabbing win. Azafaros, a

From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough
In a biotech landscape often preoccupied with the elusive fountain
